IMPORTANT behavioral actions of adrenal steroids are being elucidated by researchers in several allied fields. These behavioral actions seem to fall into two general classes -reactions to external stresses and alimentary responses. The literature demonstrating the profound interactions between stress situations and adrenocortical function is large and impressive and is the subject of a recent review [3, 4] . Less work has been done on alimentary effects of the adrenocortical hormones and this is the topic of the present paper.
There is evidence that exogenous ACTH enhances learned behavior reinforced by food or water [6, 10, 11] but it is not clear whether the enhancement is due to a specific increase in motivation or a non-specific increase in activity. Several investigators have noted a loss of body weight following treatment with a synthetic glucocorticoid (dexamethasone) and it has been suggested that this is related to an increase in general activity [1, 2, 3, 5] . The most frequently reported result following mineralocorticoid injection is a specific increase in sodium intake and a secondary increase in water intake [16] , [21] . In a recent study, Wolf, McGovern and DiCara [22] , a IThis work was supported by Grant MH 21403 from the United Association to Leo V. DiCara.
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synthetic steroid, 9 alpha flurocortisone (9 alpha F) [8, 20] , which has potent mineralocorticoid and glucocorticoid properties, was studied with regard to its sodium appetite inducing properties. It was incidentally noted that food intake decreased after injection. The anorectic effect seemed to appear about one day following a large increase in sodium intake and had a duration of from 2 to 4 days thereafter. It seemed plausible to hypothesize that the diminution in food intake was secondary to disruptions in body fluid balance resulting from the increased sodium intake coupled with increased renal sodium retention.
In the first experiment presented here food intake was measured in two groups of 9 alpha F treated rats. One group had access to supplementary sodium and the other group did not. In the second experiment the effects of several natural and synthetic corticoids possessing various degrees of mineralocorticoid and glucocorticoid activity upon food, water and salt intake was assessed.
The study of the alimentary effects of adrenal steroids is considered to be of potentially great importance for three reasons. First, it may reveal natural behavioral conStates Public Health Service and 71797 from the American Heart trol actions associated with the homeostatic functions of the adrenal cortex. Second, the data when integrated with the known physiological actions of the corticoids may shed light on the mechanism of action of alimentary control systems. Third, demonstration of a specific anorectic effect of certain steroids may lead to the development of pharmacologic agents useful for human dietary control. EXPERIMENT 1
Method
Animals. Sixteen male albino rats (Spartan) weighing between 300-400 g served in Experiment 1.
Procedures. Two groups of 8 animals, randomly assigned to each group, were formed. All rats were then given 24 had lib access to Borden undiluted condensed milk for 14 days to establish stable baseline intakes. Animals in both groups also had ad lib tap water presented in Wahmann graduated cylinders. In additon, rats in Group 2 were presented with a 0.5M NaC1 solution ad lib from a graduated Wahmann drinking tube. Food, water, and salt intakes and body weights were measured daily.
On Day 15 all rats received a single injection of 5 mg 9 alpha F suspended in sesame oil. The injection was in a volume of 0.5 ml subcutaneously.
Intake data were analyzed for each post injection day by the t-test for correlated observations until the 1st post injection day which did not differ significantly from baseline intake values. Figure 1 shows mean food intake of the two groups for the 14 day pre-injection period and for each of the 7 post-injection days. Food intakes of both groups followed very similar patterns during the post-injection period. There was a small non-significant decrease of food intake (5 g), on the first post-injection day followed by a large (2 to 3 fold decrease) persisting for the next 3 days, Group 1 (p<0.001) and Group 2 (p<0.001), and a return to normal values on the final 3 days. The salt intake of the group given supplementary 0.5M saline increased from approximately 2ml per day during the pre-injection period to about 6 ml per day on the first three postinjection days (p<0.02) and then gradually receded to normal values during the subsequent 4 days as seen in Fig. 1 . Water intakes tended to increase and body weights to decrease following injection but to avoid redundancy these data shall not be discussed further here because they are presented in detail in the more comprehensive experiment which follows.
R esu lts

EXPERIMENT 2
The preceding study showed very clearly that the diminution of food intake following 9 alpha F treatment is independent of its effects on sodium intake. The purpose of this experiment is to compare the effects of graded doses of several natural and synthetic corticoids upon food, water, and salt intake and body weight. Since the corticoids used differ widely in their relative activity upon mineral and glucose metabolism, the experiment sheds light upon which of these two functions of corticoids is responsible for the anorexia.
Method
Animals. Thirty adult male Sprague-Dawley rats of the Spartan strain weighing between 300-400 g served in this experiment.
Procedure. All animals were given 24 hr ad lib access to Borden's undiluted sweetened condensed milk for 14 days to establish stable intakes. In addition each rat also had 24 hr ad lib access to a 1.0M NaC1 solution and tap water both presented in Wahmann graducated cylinders. Following the 14 day adaptation period rats were randomly distributed to form 5 groups of 6 animals each. Intakes and body weights were measured daily.
Independent groups of animals received injections of one of 5 corticoids in an ascending series of dosages. Dose-response curves were obtained for all groups under the particular drug for that group. Drugs used were: daldosterone, DOCA, 9 alpha F, corticosterone and dexamethasone. All drugs were suspended in sesame oil immediately before injection. Injections were in volumes of 0.5 cc given subcutaneously. A variable number of post-injection days (from 4-18) followed each injection until a correlated t-test revealed no significant differences in intake from control levels. The next dose in the variable series was injected at that time. All rats received a total of 4 injections.
Intake measures within a particular drug level were 
Results
Food lntake. Table 1 shows mean food intakes for 9 alpha F at four different dosages and for all post-injection days measured. Food intakes were not significantly altered (p>0.05) following injections of 400 ug or 1.2 mg 9 alpha F. Analysis of variance showed a significant (p<0.0001) depression in food intakes at 3.6 mg; however, and the effect lasted 13 of 1 5 post-injection days following this single injection. The highest dose, 10.8 rag, also significantly (p<0.01) decreased food intakes overall and for 12 of 14 post-injection days.
All dose levels of dexamethasone produced significant anorexia in rats in this treatment group as seen in Table 2 . Four hundred ~g significantly (p<0.0001) decreased food intakes and continued its depressing effects on 4 of 5 postinjection days with probabilities ranging between (p<0.01) and (p<0.O001).
1.2 mg's significantly decreased (p<0.0001) food intakes on the injection day and 2 of 4 post-injection days. The highest dose of dexamethosone tested, 3.6 mg, reproduced more profoundly the anorexia seen with lower doses. The analysis of variance showed significantly lower (p<0.00001) intakes overall and for 17 of 18 post-injection days with probabilities ranging between (p<0.00001) and (p<0.008). The decreases seen with both 9 alpha F and dexamethasone were not only highly reliable but substantial, reducing absolute food intakes more than 50%.
Neither d-aldosterone, corticosterone nor DOCA generally affected food intakes at any of the doses injected, as shown in Tables 3, 4 and 5 respectively. However, for some reason, DOCA at a dose of 3.6 mg did significantly (p<0.04) decrease food intakes as determined from the analysis of variance. Sheffe's test showed two of nin postinjection days were signficantly reduced with probabilities of (p<0.009) and (p<0.001)respectively. However,, this effect is probably unreliable because higher and lower doses do not significantly affect food intakes. As would be expected from the food intake data body weights were significantly decreased following injections with 9 alpha F and dexamethasone. All doses dexamethasone significantly altered body weights in this group, with decreases ranging from 9 to 23%. Four hundreed ug's, 1.2 mg's and 3.6 mg's all significantly reduced body weights with probabilities of (p<0.01), (p<0.005) and (p<0.02) respectively as determined using the t-test for correlated observations. Only the highest dose of 9 alpha E 10.8 mg resulted in significantly (p< 0.01) reduced body weights as revealed by the t-test for correlated observations. None of the other corticoids tested, corticosterone, d-aldosterone or DOCA significantly affected body weight at any of the doses tested.
Water and salt intake. Water intakes were highly variable following all drugs. Although some increases were observed, these increases did not reach signficance because of the high variability of the measurements. All corticoids except dexamethasone caused significant intreases in salt intake at one or more dosage levels as reported in several previous studies [7] .
DISCUSSION
The data from Experiment 1 shows clearly that the anoxeric action of 9 alpha F on ad lib food intake is independent of its capacity to increase salt intake. Rats with salt available both increased salt intakes and decreased ad lib food intakes following a single injection of 9 alpha F. Ad lib fed rats without salt available showed exactly the same anoxeric response to this same dose of 9 alpha F. The results of the dose-response studies in Experiment 2 also suggests that a clear separation of function exists between the glucocorticoids and mineralocorticoids. The synthetic steroid 9 alpha F has high relative potencies in terms of sodium retention and liver glycogen deposition and this compound significantly elevated salt intakes and significantly decreased food intakes at two dose levels. Dexamethasone which is almost devoid of mineralocorticoid activity produced profound and long lasting decreases in food intake at all doses tested following single injections. Water and salt intakes, however, were unaffected of any concentration of dexamethasone. The results of the corticosterone injections do not fit quite so neatly into the mineral-glucocorticoid differentiation. Although classified as a glucocorticoid, corticosterone has modest sodium retention activity and relatively weak liver glycogen activity. While the sodium retention potencies of corticosterone are many times less than those of 9 alpha F, D-aldosterone or DOCA, this steroid significantly increased salt intakes in Experiment 2. No dose of corticosterone tested significantly altered 24 hr food intakes, and it is interesting to note that corticosterone is essentially no more potent than aldosterone in terms of liver glycogen deposition. As mentioned previously aldosterone was ineffective in modifying food intakes at any dose tested. While all injections of both mineralocorticoids and glucocorticoids are well above the daily secretion rates of the endogenous steroids, it is important to emphasize the differential effects on feeding noted in the results. Corticosterone even at clearly pharmacological concentrations 10.8 mg still did not significantly alter 24 hr food intakes. Neither aldosterone nor DOCA at the same concentration significantly effected daily food intake. Both synthetic glucocorticoids 9 alpha F and dexamethasone however, at much lower concentrations 9 alpha F, 3.6 mg, and dexamethasone 400 ug significantly decreased food intakes for several post injection days. It would appear more probable therefore that the anoxeric responses to 9 alpha F and dexamethesone is more closely related to possible disruptions of carbohydrate, protein and/or amino acid metabolism rather than alterations of endogenous steroid secretion rates. The results of these studies support the conclusions that mineralocorticoids can elicit increased salt appetite without anorexia and the glucocorticoids can produce significant decreases in food intake without elevations in salt intake.
The fact that one of the major actions of glucocorticoids on carbohydrate metabolism is the increased production of glucose [9] suggests at least two possible alternatives to account for the decreases in food intake observed in these experiments. From the earliest statement of the glucostatic theory [12] the difference in A-V glucose utilization has been widely accepted as the mechanism responsible for the regulation of food intake. A large body of literature including both central and peripheral injections of glucose support the notion of glucose sensitive central mechanisms involved in food regulation. Oomura and his associates [ 1 4, 1 5 ] using electrophysiological and microelectrophoretic techniques have discussed the existence of reciprocally connected glucose sensitive systems in the ventromedial and ventrolateral areas of the hypothalamus. Epstein and his associates [191 have used a glucose analogue, 2-Deoxy-d-glucose, to create a glucoprivation in central cells and have observed increases in food intakes following these manipulations. We might speculate that our glucocorticoid injections significantly altered the pattern of A-V glucose utilization for several days. These changes might then be monitored by glucose sensitive cells in the ventromedial area of the hypothalamus. Increased activity from these supposedly satiety neurons would then inhibit activity from ventrolateral feeding neurons resulting in a significant decrease in food intake.
An alternative explanation of our results is related to the hepatic glucose receptor system described by Russek [17] . Russek [ 17 ] has reported profound and extended anorexia following various glucose loads in dogs. Niijima [13] has also demonstrated changes in electrophysiologically recorded activity from hepatic cells as a consequence of glucose challenge. According to Russek [18] , information from these hepatic glucose sensitive cells could then be relayed over vagal and other afferents to hypothalamic areas. The glucocorticoids might directly affect the glucose sensitive hepatic cells described by Russek. This explanation is increasingly plausbile when it is recalled that one of the major actions of the glucocorticoids is the deposition of liver glycogen at liver sites. A problem for both glucose sensitive systems is the relative time course of the effects observed by us. Either central or peripheral glucose producing anorexia and 2-deoxy-d-glucose elicited eating following central or peripheral administration are short term effects. All studies report intakes returning to normal within 24 hr. Our animals, however, while not debilitated, continued to eat less and lose weight for as long as 20 days following a single subcutaneous injection. Although our data cannot estimate the relative time course of metabolic effects following the injections, a recent study by Elliott, Peters and White [5 ] does provide some information concerning dexamethasone. They reported a significant reduction in the amino-acid incorporating ability of rat skeletal muscle ribosomes in vitro following injection with glucocorticoids including dexamethasone. Diminished ribosomal activity was observed 48 hr following a 150 ug dose of dexamethasone i.p. This study also demonstrates the profound effects of glucocorticoids on protein and amino-acid metabolism and suggests another alternative as the possible mediator of the observed anorexic responses. Clearly more experiments are necessary to resolve the relative contributions of protein, hepatic, and hypothalamic mechanism responsible for glucocorticoid induced anorexia.
